Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Technology Breakthrough in Deep Light Imaging to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 13 Jul 2023

Optical coherence tomography (OCT), an important form of light imaging, operates on the principle of light backscattering within the sample under observation, similar to how light gets scattered in fog due to water droplets possessing different refractive indices than the air. More...

Just as the scattering makes it hard to see through fog, the scattering by cellular components and smaller constituents in biological tissue also complicates imaging tasks. Specifically, acquiring a clear signal from depths surpassing 1mm presents significant difficulties, chiefly because of intervening tissue. Now, a technological breakthrough in OCT is set to revolutionize applications in fields like ophthalmology, dermatology, cardiology, and early cancer detection, as well as improve disease diagnosis.

Traditional understanding holds that the OCT signal is largely influenced by light that has experienced a single backscattering event, while light that has been scattered numerous times hampers image creation. An international team of researchers, in collaboration with the University of St Andrews (Scotland, UK), have uncovered a contrasting perspective. They suggest that selectively gathering multiply scattered light could enhance image contrast at depth, especially in highly scattering samples. The researchers further demonstrated how this technique could be applied in a simple way with minimal additional optics, by shifting the light delivery and collection pathways. The team is confident that their ground-breaking discovery has the potential to challenge existing conventions and bring about a significant shift in retrieving images at depth.

“The unique configuration, supported by our modeling, should redefine our view on OCT signal formation – and we can now use this insight to extract more information and to improve diagnosis of disease,” said Dr. Peter Andersen, co-corresponding author from Technical University of Denmark.

Related Links:
University of St Andrews 


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.